Eva Herweijer
Overview
Explore the profile of Eva Herweijer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Astorga Alsina A, Herweijer E, Lei J
J Infect Dis
. 2025 Jan;
PMID: 39879631
Background: Sweden introduced HPV vaccination in 2006, administered through opportunistic, subsidized, catch-up and school-based programs. Notably, genital warts (GW) are the first observable clinical outcome following infection by HPV-6/11, targeted...
2.
Blum M, Geurtsen J, Herweijer E, Sarnecki M, Spiessens B, Reynolds Diogo G, et al.
Epidemiol Infect
. 2025 Jan;
153():e4.
PMID: 39757943
Extraintestinal pathogenic (ExPEC) causes invasive disease (IED), including bacteraemia and (uro)sepsis, resulting in a high disease burden, especially among older adults. This study describes the epidemiology of IED in England...
3.
Barker M, Koiv K, Magnusdottir I, Milbourn H, Wang B, Du X, et al.
Nat Commun
. 2024 Sep;
15(1):8124.
PMID: 39327436
Individuals with mental illness are at higher risk of severe COVID-19 outcomes. However, previous studies on the uptake of COVID-19 vaccination in this population have reported conflicting results. Using data...
4.
Hu K, Barker M, Herweijer E, Wang J, Feldman A, Lu D, et al.
Lancet Public Health
. 2024 Aug;
9(9):e674-e683.
PMID: 39214636
Background: Despite documented mental illness-related disparities in cervical cancer screening and incidence, insufficient data exist on differences in cervical cancer prevention strategies, such as human papillomavirus (HPV) vaccination. We aimed...
5.
Herweijer E, Schwamborn K, Bollaerts K, Spillmann A, Cattaert T, Verstraeten T, et al.
Gastro Hep Adv
. 2024 Aug;
1(4):531-537.
PMID: 39132057
Background And Aims: Recently, cholera vaccine use was shown to be associated with a reduced risk of death in patients with colorectal cancer (CRC). However, evidence on heterologous effects of...
6.
Herweijer E, Hu K, Wang J, Lu D, Sparen P, Adami H, et al.
PLoS Med
. 2024 Mar;
21(3):e1004372.
PMID: 38527071
Background: Women with mental illness experience an increased risk of cervical cancer. The excess risk is partly due to low participation in cervical screening; however, it remains unknown whether it...
7.
Herweijer E, Wang J, Hu K, Valdimarsdottir U, Adami H, Sparen P, et al.
JAMA Netw Open
. 2023 Sep;
6(9):e2336213.
PMID: 37773493
Importance: Individuals with a mental disorder experience substantial health disparity and are less likely to participate in cervical screening and human papillomavirus vaccination. Additionally, this population may benefit less from...
8.
Wang J, Herweijer E, Kleppe S, Hartwig S, Velicer C, Koro C, et al.
Prev Med Rep
. 2023 Aug;
35:102342.
PMID: 37584061
Background: Close monitoring of vaccination coverage is important for cervical cancer prevention efforts. The study aims to describe the HPV vaccination coverage by dose in girls eligible for HPV vaccination...
9.
Hu K, Wang J, Sparen P, Herweijer E, Sjolander A, Adami H, et al.
Lancet Public Health
. 2023 Mar;
8(4):e266-e275.
PMID: 36965981
Background: WHO aims to eliminate cervical cancer. Whether women with mental illness constitute a group at high-risk and require targeted prevention initiatives remains unknown. We aimed to assess whether women...
10.
Sundstrom K, Herweijer E, Wang J
Prev Med
. 2020 Dec;
144:106382.
PMID: 33359012
We here discuss human papillomavirus (HPV)-based screening avenues to achieve elimination of cervical cancer as a public health problem in high-income country (HIC) settings, covering both the most recent data...